Ziva D Cooper

Title(s)Associate Professor-in-Residence, Psychiatry and Biobehavioral Sciences
vCardDownload vCard
    Other Positions
    Title(s)Associate Professor-in-Residence, Anesthesiology

    Collapse Research 
    Collapse Research Activities and Funding
    Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and ß-caryophyllene
    NIH R01AT010762Feb 15, 2020 - Jan 31, 2025
    Role: Principal Investigator
    Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women
    NIH R01DA047296Sep 15, 2019 - Jun 30, 2024
    Role: Principal Investigator
    Impact of vaporized cannabis with varying cannabidiol and THC ratios on opioid abuse-liability and analgesia
    NIH R21DA046614Aug 1, 2018 - Jul 31, 2021
    Role: Co-Principal Investigator
    Preclinical Synthetic Cannabinoid Vapor Inhalation: Acute and Chronic Effects
    NIH R01DA039123May 1, 2015 - Apr 30, 2019
    Role: Co-Principal Investigator
    Synthesis of Smokable Synthetic Cannabinoids ('Spice') for Human Study
    NIH R21DA036809Aug 1, 2014 - Jul 31, 2017
    Role: Principal Investigator
    Behavioral and Physiological Effects of Marijuana on Smoked Cocaine
    NIH K01DA027755Apr 1, 2010 - Mar 31, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Addict Biol. 2022 07; 27(4):e13183. Haney M, Bedi G, Cooper ZD, Herrmann ES, Reed SC, Foltin RW, Kingsley PJ, Marnett LJ, Patel S. PMID: 35754107; PMCID: PMC9245164.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum. Geburtshilfe Frauenheilkd. 2022 May; 82(5):517-527. First OK, MacGibbon KW, Cahill CM, Cooper ZD, Gelberg L, Cortessis VK, Mullin PM, Fejzo MS. PMID: 35528189; PMCID: PMC9076215.
      View in: PubMed   Mentions:    Fields:    
    3. Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States. Exp Clin Psychopharmacol. 2022 Apr 25. Lake S, Assaf RD, Gorbach PM, Cooper ZD. PMID: 35467920.
      View in: PubMed   Mentions:    Fields:    
    4. Drugs of Misuse: Focus on Vascular Dysfunction. Can J Cardiol. 2022 Sep; 38(9):1364-1377. Middlekauff HR, Cooper ZD, Strauss SB. PMID: 35462024; PMCID: PMC9474615.
      View in: PubMed   Mentions:    Fields:    
    5. Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic. Am J Drug Alcohol Abuse. 2022 05 04; 48(3):321-327. Assaf RD, Gorbach PM, Cooper ZD. PMID: 35130464; PMCID: PMC9308664.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    6. Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States. Cannabis Cannabinoid Res. 2022 Jan 24. Lake S, Assaf RD, Gorbach PM, Cooper ZD. PMID: 35073161.
      View in: PubMed   Mentions:    Fields:    
    7. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. J Natl Cancer Inst Monogr. 2021 11 28; 2021(58):114-122. Cooper ZD, Abrams DI, Gust S, Salicrup A, Throckmorton DC. PMID: 34850896; PMCID: PMC8783595.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    8. The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs. Cannabis Cannabinoid Res. 2021 Nov 22. Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ. PMID: 34813374.
      View in: PubMed   Mentions:    Fields:    
    9. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis Cannabinoid Res. 2021 Sep 27. Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. PMID: 34569849.
      View in: PubMed   Mentions:    Fields:    
    10. A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans. Br J Clin Pharmacol. 2022 01; 88(1):347-355. Arout CA, Haney M, Herrmann ES, Bedi G, Cooper ZD. PMID: 34223660.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. Am J Drug Alcohol Abuse. 2021 09 03; 47(5):535-547. Kozak K, H Smith P, Lowe DJE, Weinberger AH, Cooper ZD, Rabin RA, George TP. PMID: 34280058; PMCID: PMC9144491.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates. Exp Clin Psychopharmacol. 2021 Apr; 29(2):137-146. Cooper ZD, Evans SM, Foltin RW. PMID: 34043398; PMCID: PMC8376089.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    13. Motivational interviewing to treat substance use disorders in the emergency department: A scoping review. Am J Emerg Med. 2022 01; 51:414-417. Siegel R, Sullivan N, Monte AA, Vargas NM, Cooper ZD, Ma Y, Meltzer AC. PMID: 33840549.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. Addict Biol. 2021 07; 26(4):e12993. Arout CA, Cooper ZD, Reed SC, Foltin RW, Comer SD, Levin FR, Haney M. PMID: 33389797; PMCID: PMC8225547.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control. Int J Clin Pract. 2021 Aug; 75(8):e13871. Sihota A, Smith BK, Ahmed SA, Bell A, Blain A, Clarke H, Cooper ZD, Cyr C, Daeninck P, Deshpande A, Ethans K, Flusk D, Le Foll B, Milloy MJ, Moulin DE, Naidoo V, Ong M, Perez J, Rod K, Sealey R, Sulak D, Walsh Z, O'Connell C. PMID: 33249713; PMCID: PMC8365704.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacol Biochem Behav. 2020 12; 199:173059. Sholler DJ, Huestis MA, Amendolara B, Vandrey R, Cooper ZD. PMID: 33086126; PMCID: PMC7725960.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    17. Sex-dependent effects of alcohol administration on the urge to use cannabis. Exp Clin Psychopharmacol. 2021 Dec; 29(6):689-695. Venegas A, Meredith LR, Green R, Cooper ZD, Ray LA. PMID: 32658530; PMCID: PMC8409139.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    18. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. Alcohol Alcohol. 2020 Jun 25; 55(4):416-423. Venegas A, Meredith LR, Cooper ZD, Towns B, Ray LA. PMID: 32328657; PMCID: PMC7307319.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    19. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLoS Med. 2019 11; 16(11):e1002967. Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, Ware MA, Milloy MJ. PMID: 31743343; PMCID: PMC6863529.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    20. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies. Am J Drug Alcohol Abuse. 2019; 45(6):580-595. Cooper ZD, Abrams DI. PMID: 31687845; PMCID: PMC7279709.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Cognitive function in aging cocaine smokers. J Psychopharmacol. 2019 07; 33(7):801-810. Chao T, Haney M, Cooper ZD, Vadhan NP, Van Dam NT, Van Snellenberg J, Bedi G. PMID: 31169441.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Necessity of addressing motivations for cannabis use to guide research. Am J Drug Alcohol Abuse. 2019; 45(6):547-550. Cooper ZD, Adinoff B. PMID: 31755836; PMCID: PMC7307379.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    23. Cannabis legalization: progress in harm reduction approaches for substance use and misuse. Am J Drug Alcohol Abuse. 2019; 45(6):707-712. Adinoff B, Cooper ZD. PMID: 31755837.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Addict Biol. 2019 07; 24(4):765-776. Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. PMID: 30378231; PMCID: PMC8167505.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Social motivational processing and interpersonal function in aging cocaine smokers. Addict Biol. 2019 09; 24(5):1044-1055. Bedi G, Hao X, Van Dam NT, Cooper ZD, Rubin E, Vadhan NP, Marino L, Haney M. PMID: 30328665.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addict Biol. 2019 07; 24(4):707-716. Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR. PMID: 29659126; PMCID: PMC6191371.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    27. Cannabis and the Opioid Crisis. Cannabis Cannabinoid Res. 2018; 3(1):108-116. Piomelli D, Weiss S, Boyd G, Pacula RL, Cooper Z. PMID: 29789812; PMCID: PMC5931647.
      View in: PubMed   Mentions: 3     Fields:    
    28. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology. 2018 09; 43(10):2046-2055. Cooper ZD, Bedi G, Ramesh D, Balter R, Comer SD, Haney M. PMID: 29463913; PMCID: PMC6098090.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    29. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073. Neuropharmacology. 2018 05 15; 134(Pt A):92-100. Cooper ZD, Poklis JL, Liu F. PMID: 29146503; PMCID: PMC5951724.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. Neuropsychopharmacology. 2018 Jan; 43(1):34-51. Cooper ZD, Craft RM. PMID: 28811670; PMCID: PMC5719093.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimals
    31. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Drug Alcohol Depend. 2017 09 01; 178:340-347. Cooper ZD, Johnson KW, Vosburg SK, Sullivan MA, Manubay J, Martinez D, Jones JD, Saccone PA, Comer SD. PMID: 28688296.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members. Cannabis Cannabinoid Res. 2017; 2(1):155-159. Piomelli D, Cooper Z, Abrams D, Grant I, Patel S. PMID: 28861515; PMCID: PMC5569624.
      View in: PubMed   Mentions: 1     Fields:    
    33. Sex-dependent effects of cannabis-induced analgesia. Drug Alcohol Depend. 2016 Oct 01; 167:112-20. Cooper ZD, Haney M. PMID: 27522535; PMCID: PMC5037015.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    34. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Curr Psychiatry Rep. 2016 May; 18(5):52. Cooper ZD. PMID: 27074934; PMCID: PMC4923337.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    35. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology (Berl). 2016 07; 233(13):2469-78. Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. PMID: 27085870; PMCID: PMC5302052.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    36. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82. Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. PMID: 26708108; PMCID: PMC4908634.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    37. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol. 2016 07; 21(4):895-903. Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, Comer SD. PMID: 25975386; PMCID: PMC4644513.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    38. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology. 2015 Oct; 40(11):2489-98. Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. PMID: 25881117; PMCID: PMC4569951.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    39. Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Curr Addict Rep. 2014 Jun 01; 1(2):137-143. Balter RE, Cooper ZD, Haney M. PMID: 24955304; PMCID: PMC4061701.
      View in: PubMed   Mentions: 27  
    40. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 2014 Mar 01; 136:85-91. Cooper ZD, Haney M. PMID: 24440051; PMCID: PMC4518446.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    41. Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts. Behav Pharmacol. 2013 Sep; 24(5-6):504-16. Comer SD, Metz VE, Cooper ZD, Kowalczyk WJ, Jones JD, Sullivan MA, Manubay JM, Vosburg SK, Smith ME, Peyser D, Saccone PA. PMID: 23839029; PMCID: PMC4056333.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Marijuana's dose-dependent effects in daily marijuana smokers. Exp Clin Psychopharmacol. 2013 Aug; 21(4):287-93. Ramesh D, Haney M, Cooper ZD. PMID: 23937597; PMCID: PMC4547548.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    43. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology. 2013 Nov; 38(12):2427-38. Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, Haney M, Foltin RW. PMID: 23736314; PMCID: PMC3799062.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    44. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 2013 Aug; 154(8):1442-8. Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD. PMID: 23707283; PMCID: PMC3770461.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    45. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology. 2013 Sep; 38(10):1984-92. Cooper ZD, Comer SD, Haney M. PMID: 23609132; PMCID: PMC3746706.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    46. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013 Jul; 38(8):1557-65. Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. PMID: 23443718; PMCID: PMC3682150.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansPHPublic Health
    47. Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques. Horm Behav. 2013 Jan; 63(1):105-13. Cooper ZD, Foltin RW, Evans SM. PMID: 23098805; PMCID: PMC3540131.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    48. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry. 2013 Feb 01; 73(3):242-8. Haney M, Bedi G, Cooper ZD, Glass A, Vosburg SK, Comer SD, Foltin RW. PMID: 22939992; PMCID: PMC3522776.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    49. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addict Biol. 2013 Nov; 18(6):993-1002. Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M. PMID: 22741619; PMCID: PMC3465638.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    50. Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers. Behav Pharmacol. 2012 Jun; 23(3):271-9. Cooper ZD, Sullivan MA, Vosburg SK, Manubay JM, Haney M, Foltin RW, Evans SM, Kowalczyk WJ, Saccone PA, Comer SD. PMID: 22495183; PMCID: PMC3341961.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    51. Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health. Addiction. 2012 Mar; 107(3):642-9. Roux P, Tindall C, Fugon L, Murray J, Vosburg SK, Saccone P, Sullivan MA, Manubay JM, Cooper ZD, Jones JD, Foltin RW, Comer SD. PMID: 21939462; PMCID: PMC3335397.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addict Biol. 2013 Sep; 18(5):872-81. Bedi G, Cooper ZD, Haney M. PMID: 22260337; PMCID: PMC3335956.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    53. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opin Investig Drugs. 2012 Feb; 21(2):169-78. Cooper ZD, Jones JD, Comer SD. PMID: 22233449; PMCID: PMC3314383.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    54. Oxycodone lengthens reproductions of suprasecond time intervals in human research volunteers. Behav Pharmacol. 2011 Aug; 22(4):354-61. Gooch CM, Rakitin BC, Cooper ZD, Comer SD, Balsam PD. PMID: 21750426; PMCID: PMC3182820.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology (Berl). 2010 Oct; 212(3):369-78. Cooper ZD, Shi YG, Woods JH. PMID: 20686752; PMCID: PMC3001287.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    56. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl). 2010 Aug; 211(2):233-44. Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW. PMID: 20521030; PMCID: PMC3323354.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    57. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology (Berl). 2010 Aug; 211(2):141-8. Cooper ZD, Haney M. PMID: 20490465; PMCID: PMC2923559.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    58. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction. 2010 Apr; 105(4):709-18. Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD. PMID: 20403021; PMCID: PMC3489277.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    59. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers. Psychopharmacology (Berl). 2010 Jan; 208(1):45-55. Comer SD, Cooper ZD, Kowalczyk WJ, Sullivan MA, Evans SM, Bisaga AM, Vosburg SK. PMID: 19859698; PMCID: PMC3320722.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    60. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):219-29. Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. PMID: 19800183; PMCID: PMC3349347.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    61. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 2009 Aug 01; 103(3):107-13. Cooper ZD, Haney M. PMID: 19443132; PMCID: PMC2776770.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    62. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry. 2009 Apr; 21(2):104-12. Cooper ZD, Haney M. PMID: 19367504; PMCID: PMC2731700.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    63. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Ann Emerg Med. 2009 Sep; 54(3):409-20. Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. PMID: 19013687; PMCID: PMC3357128.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    64. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. J Pharmacol Exp Ther. 2008 Sep; 326(3):920-9. Cooper ZD, Truong YN, Shi YG, Woods JH. PMID: 18515643; PMCID: PMC3328857.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    65. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol. 2008 Jun; 13(2):188-95. Cooper ZD, Haney M. PMID: 18279497; PMCID: PMC2731704.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimals
    66. Cocaine esterase: interactions with cocaine and immune responses in mice. J Pharmacol Exp Ther. 2007 Feb; 320(2):926-33. Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. PMID: 17114567.
      View in: PubMed   Mentions: 38     Fields:    Translation:Animals
    67. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol Pharmacol. 2006 Dec; 70(6):1885-91. Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. PMID: 16968810.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    68. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. J Neuroendocrinol. 2001 Oct; 13(10):862-74. Houshyar H, Cooper ZD, Woods JH. PMID: 11679055.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    69. Hybrid laparoscopic flexure takedown and open procedure for rectal resection is associated with significantly shorter length of stay than equivalent open resection. Dis Colon Rectum. 2001 Jul; 44(7):927-35. Vithiananthan S, Cooper Z, Betten K, Stapleton GS, Carter J, Huang EH, Whelan RL. PMID: 11496070.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Ziva's Networks
    Concepts (252)
    Derived automatically from this person's publications.
    Co-Authors (9)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department